“…Furthermore, we found that introduction of a substituent (e.g., MeO, N 3 , Cl, F, etc.) to the meta position of the C2-benzoyl group of the second-generation taxoids, enhanced the activities 2-3 orders of magnitude higher than the parent drugs against different types of the drug-resistant cancer cells (Ojima & Das, 2009). The antitumor activity of SB-T-1214 (Figure 3), one of the leading candidates among the new generation taxoids studied in our laboratory, was assayed in vivo against a Pgp+ DLD-1 human colon tumor xenograft in SCID mice, as well as against highly drug-resistant CFPAC-1 pancreatic tumor xenografts.…”